Insights

Growing Market Presence Fresenius Kabi France operates in the vital healthcare sector with a broad portfolio of generic medications, infusion therapies, and medical devices, indicating opportunities to expand partnerships with hospitals, clinics, and healthcare providers seeking reliable supply of essential medicines.

Focus on Biosimilars Their emphasis on biosimilars for autoimmune and oncological treatments presents potential sales opportunities with specialty clinics and research institutions interested in affordable, high-quality biologic therapies.

Innovation in Blood Therapy With offerings in transfusion medicine and cellular therapies, there is a chance to connect with blood banks, transfusion centers, and biotech firms involved in blood component management and advanced blood treatment systems.

Emerging Revenue Potential Although currently generating between 1 million and 10 million dollars, Fresenius Kabi France's evolving product line and focus on innovative therapies suggest significant growth opportunities within the healthcare ecosystem.

Strategic Partnership Opportunities The company's specialization in critical care medicines and medical devices positions it as a potential partner for health system integrators, research pilots, and clinical service providers looking to enhance treatment capabilities.

Similar companies to Fresenius Kabi France

Fresenius Kabi France Tech Stack

Media & News

Fresenius Kabi France's Email Address Formats

Fresenius Kabi France uses at least 2 format(s):
Fresenius Kabi France Email FormatsExamplePercentage
First.Last@fresenius-kabi.comJohn.Doe@fresenius-kabi.com
94%
Last.First@fresenius-kabi.comDoe.John@fresenius-kabi.com
1%
First.Middle@fresenius-kabi.comJohn.Michael@fresenius-kabi.com
1%
FirstLast@fresenius-kabi.comJohnDoe@fresenius-kabi.com
1%
FLast@fresenius-kabi.comJDoe@fresenius-kabi.com
1%
First.MiddleLast@fresenius-kabi.comJohn.MichaelDoe@fresenius-kabi.com
1%
LastF@fresenius-kabi.comDoeJ@fresenius-kabi.com
1%

Frequently Asked Questions

What is Fresenius Kabi France's official website and social media links?

Minus sign iconPlus sign icon
Fresenius Kabi France's official website is fresenius-kabi.fr and has social profiles on LinkedIn.

What is Fresenius Kabi France's SIC code NAICS code?

Minus sign iconPlus sign icon
Fresenius Kabi France's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Fresenius Kabi France have currently?

Minus sign iconPlus sign icon
As of December 2025, Fresenius Kabi France has approximately 1K employees across 4 continents, including EuropeAfricaAsia. Key team members include Chief Information Officer (dsi / Cio): S. L.Chief Financial Officer: C. C.Head Of Supply Chain France & Operations Benelux: H. T.. Explore Fresenius Kabi France's employee directory with LeadIQ.

What industry does Fresenius Kabi France belong to?

Minus sign iconPlus sign icon
Fresenius Kabi France operates in the Pharmaceutical Manufacturing industry.

What is Fresenius Kabi France's email format?

Minus sign iconPlus sign icon
Fresenius Kabi France's email format typically follows the pattern of First.Last@fresenius-kabi.com. Find more Fresenius Kabi France email formats with LeadIQ.

Fresenius Kabi France

Pharmaceutical ManufacturingÎle-de-france, France1001-5000 Employees

Fresenius Kabi est une entreprise de santé mondiale spécialisée dans les médicaments et les dispositifs médicaux vitaux dans la perfusion, la transfusion et la nutrition clinique. Les médicaments, technologies et services de Fresenius Kabi sont utilisés pour aider à soigner les patients en situation d’urgence ou atteints de maladies chroniques. Le portefeuille de produits de Fresenius Kabi comprend une gamme complète de médicaments génériques administrés par voie intraveineuse, des thérapies par perfusion, des produits de nutrition clinique ainsi que les dispositifs médicaux nécessaires à l’administration de ces produits. Dans le domaine des biosimilaires, nous nous concentrons sur les maladies auto-immunes et l'oncologie. En 2019, le premier produit biosimilaire de Fresenius Kabi a été lancé. Dans le domaine de la médecine transfusionnelle et des thérapies cellulaires, Fresenius Kabi propose des produits pour le prélèvement et le traitement des composants sanguins ainsi que pour le traitement du sang par des systèmes d'aphérèse. Informations d’utilisation et règles de vie en communauté numérique/charte de modération : https://www.fresenius-kabi.com/fr/documents/Informations_Utilisation_Reseaux_Sociaux.pdf

Section iconCompany Overview

SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
1001-5000

Section iconMedia & News

Section iconFunding & Financials

  • $1M$10M

    Fresenius Kabi France's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Fresenius Kabi France's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.